219 related articles for article (PubMed ID: 31720873)
1. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
[TBL] [Abstract][Full Text] [Related]
2. TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway.
Huang H; Yang Y; Zhang W; Liu X; Yang G
FEBS Open Bio; 2020 Aug; 10(8):1542-1549. PubMed ID: 32530571
[TBL] [Abstract][Full Text] [Related]
3. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
4. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.
Liu X; Liao W; Yuan Q; Ou Y; Huang J
Oncotarget; 2015 Oct; 6(33):34309-20. PubMed ID: 26418879
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
6. TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer.
Liu Y; Zhu K; Guan X; Xie S; Wang Y; Tong Y; Guo L; Zheng H; Lu R
J Ovarian Res; 2021 Oct; 14(1):128. PubMed ID: 34598710
[TBL] [Abstract][Full Text] [Related]
7. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
[TBL] [Abstract][Full Text] [Related]
8. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
[TBL] [Abstract][Full Text] [Related]
9. Silencing TTK expression inhibits the proliferation and progression of prostate cancer.
Chen S; Wang J; Wang L; Peng H; Xiao L; Li C; Lin D; Yang K
Exp Cell Res; 2019 Dec; 385(1):111669. PubMed ID: 31605696
[TBL] [Abstract][Full Text] [Related]
10. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
[TBL] [Abstract][Full Text] [Related]
11. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.
Chen S; Wang Y; Ni C; Meng G; Sheng X
Biomed Pharmacother; 2016 Oct; 83():898-904. PubMed ID: 27522003
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.
Liu M; Fu Z; Wu X; Du K; Zhang S; Zeng L
Tumour Biol; 2016 May; 37(5):6155-68. PubMed ID: 26614430
[TBL] [Abstract][Full Text] [Related]
14. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
15. Mps1/TTK: a novel target and biomarker for cancer.
Xie Y; Wang A; Lin J; Wu L; Zhang H; Yang X; Wan X; Miao R; Sang X; Zhao H
J Drug Target; 2017 Feb; 25(2):112-118. PubMed ID: 27819146
[TBL] [Abstract][Full Text] [Related]
16. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
Maire V; Baldeyron C; Richardson M; Tesson B; Vincent-Salomon A; Gravier E; Marty-Prouvost B; De Koning L; Rigaill G; Dumont A; Gentien D; Barillot E; Roman-Roman S; Depil S; Cruzalegui F; Pierré A; Tucker GC; Dubois T
PLoS One; 2013; 8(5):e63712. PubMed ID: 23700430
[TBL] [Abstract][Full Text] [Related]
17. PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.
Cheng Y; Zhu Y; Xu W; Xu J; Yang M; Chen P; Zhao J; Geng L; Gong S
Mol Carcinog; 2018 Aug; 57(8):1017-1029. PubMed ID: 29637628
[TBL] [Abstract][Full Text] [Related]
18. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
19. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
Gao YH; Qu SS; Cao LQ; Yao M
Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
